设计,合成,结构-活性关系 (SAR) 和新型阿里硫胺作为选择性Nav1.7抑制剂的止痛效应研究
Ruokun Wu1, Wenfeng Chen1, Xueyuan Wang2
1College of Science, Nanjing Forestry University, No. 159 Longpan Road, Nanjing, 210037, PR China.
European journal of medicinal chemistry
|August 29, 2025
概括
研究人员开发了针对Nav1.7通道的新硫胺化合物来缓解慢性疼痛. 化合物50具有强烈的止痛效果和安全性,这表明它可能用于治疗神经性疼痛.
科学领域:
- 医学化学
- 神经科学
- 药理学
背景情况:
- 慢性疼痛严重影响人类的生活质量.
- 纳维1.7电压通道参与疼痛信号,使其成为疼痛管理的关键目标.
- 抑制Nav1.7功能是缓解疼痛的一种有希望的策略.
研究的目的:
- 设计和合成针对Nav1.7的新型胺化合物.
- 评估这些化合物的生物特性,包括治疗神经病痛的有效性和安全性.
主要方法:
- 新型胺化合物的合成.
- 在体外和体内实验评估.
- 评估微体稳定性,选择性,hERG通道相互作用和药物动力学特征.
- 分子对接研究以阐明结合相互作用.
主要成果:
- 化合物50表现出优异的微体稳定性,体内安全性和高选择性.
- 与疼痛模型中的阳性对照相比,化合物50的起作用速度更快,并且具有更高的止痛效果.
- 分子对接显示了化合物50和Nav1.7之间的结和π-π堆叠相互作用.
结论:
- 化合物50具有良好的药理和安全性.
- 该化合物显示出作为神经病痛治疗候选药物的显著潜力.
- 需要对治疗慢性疼痛的化合物50进行进一步的研究.
相关概念视频
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Local Anesthetics: Chemistry and Structure-Activity Relationship
5.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
5.4K
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K

![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
